ATE200894T1 - Pharmazeutische mittel enthaltend perfluoralkylhaltige metallkomplexe und ihre verwendung in der tumortherapie und interventionellen radiologie - Google Patents

Pharmazeutische mittel enthaltend perfluoralkylhaltige metallkomplexe und ihre verwendung in der tumortherapie und interventionellen radiologie

Info

Publication number
ATE200894T1
ATE200894T1 AT97903278T AT97903278T ATE200894T1 AT E200894 T1 ATE200894 T1 AT E200894T1 AT 97903278 T AT97903278 T AT 97903278T AT 97903278 T AT97903278 T AT 97903278T AT E200894 T1 ATE200894 T1 AT E200894T1
Authority
AT
Austria
Prior art keywords
pharmaceutical agents
metal complexes
interventional radiology
perfluoralkyl
tumor therapy
Prior art date
Application number
AT97903278T
Other languages
German (de)
English (en)
Inventor
Johannes Platzek
Ulrich Niedballa
Bernd Raduechel
Wolfgang Schlecker
Hanns-Joachim Weinmann
Thomas Frenzel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE200894T1 publication Critical patent/ATE200894T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97903278T 1996-02-23 1997-02-14 Pharmazeutische mittel enthaltend perfluoralkylhaltige metallkomplexe und ihre verwendung in der tumortherapie und interventionellen radiologie ATE200894T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19608278A DE19608278A1 (de) 1996-02-23 1996-02-23 Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
PCT/EP1997/000684 WO1997030969A1 (de) 1996-02-23 1997-02-14 Pharmazeutische mittel enthaltend perfluoralkylhaltige metallkomplexe und ihre verwendung in der tumortherapie und interventionellen radiologie

Publications (1)

Publication Number Publication Date
ATE200894T1 true ATE200894T1 (de) 2001-05-15

Family

ID=7787153

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903278T ATE200894T1 (de) 1996-02-23 1997-02-14 Pharmazeutische mittel enthaltend perfluoralkylhaltige metallkomplexe und ihre verwendung in der tumortherapie und interventionellen radiologie

Country Status (14)

Country Link
EP (1) EP0882010B1 (enExample)
JP (1) JP2000504736A (enExample)
AT (1) ATE200894T1 (enExample)
AU (1) AU1769297A (enExample)
CA (1) CA2247253A1 (enExample)
DE (2) DE19608278A1 (enExample)
DK (1) DK0882010T3 (enExample)
ES (1) ES2158493T3 (enExample)
GR (1) GR3036306T3 (enExample)
NO (1) NO323547B1 (enExample)
PT (1) PT882010E (enExample)
TW (1) TW477699B (enExample)
WO (1) WO1997030969A1 (enExample)
ZA (1) ZA971537B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919433A (en) * 1996-12-04 1999-07-06 Schering Aktiengesellschaft Macrocyclic metal complex carboxylic acids, their use as well as process for their production
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19731591C2 (de) * 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
US6461587B1 (en) 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
JP2005501082A (ja) * 2001-08-03 2005-01-13 グラクソ　グループ　リミテッド 界面活性剤化合物およびその使用
AU2003249999A1 (en) * 2002-07-10 2004-02-02 Hans Robert Kalbitzer 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
DE102005008309A1 (de) * 2005-02-17 2006-08-24 Schering Ag Pharmazeutische Mittel enthaltend fluoralkylhaltige Metallkomplexe und Epothilone
ITMI20131225A1 (it) * 2013-07-22 2015-01-23 Miteni Spa Nuovi composti organici fluorurati, procedimento per la loro preparazione e loro uso come intermedi di sintesi
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
EP3544964B1 (en) 2016-11-28 2020-06-17 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
IL321215B2 (en) 2018-11-23 2026-05-01 Bayer Ag Contrast media formulation and process for its preparation
JP2024020674A (ja) * 2021-01-06 2024-02-15 Ａｇｃ株式会社 ペプチド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803869C2 (de) * 1978-01-30 1983-12-29 Ethicon, Inc., 08876 Somerville, N.J. Injizierbare Embolisations- und Okklusionslösung
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JP2657393B2 (ja) * 1988-05-18 1997-09-24 日本化薬株式会社 化学塞栓療法剤
FR2682110B1 (fr) * 1991-10-02 1995-05-24 Atta Ligands amphiphiles perfluoroalkyles leurs complexes metalliques et leurs utilisations dans des preparations a usage therapeutique.
EP0673655A1 (en) * 1992-03-19 1995-09-27 Daikin Industries, Limited Mri contrast medium and diagnostic method
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same

Also Published As

Publication number Publication date
CA2247253A1 (en) 1997-08-28
NO323547B1 (no) 2007-06-11
GR3036306T3 (en) 2001-10-31
DE59703468D1 (de) 2001-06-07
AU1769297A (en) 1997-09-10
WO1997030969A1 (de) 1997-08-28
DE19608278A1 (de) 1997-08-28
EP0882010A1 (de) 1998-12-09
JP2000504736A (ja) 2000-04-18
PT882010E (pt) 2001-10-30
NO983875L (no) 1998-10-22
ES2158493T3 (es) 2001-09-01
NO983875D0 (no) 1998-08-21
ZA971537B (en) 1997-10-30
DK0882010T3 (da) 2001-08-20
TW477699B (en) 2002-03-01
EP0882010B1 (de) 2001-05-02

Similar Documents

Publication Publication Date Title
DE59703468D1 (de) Pharmazeutische mittel enthaltend perfluoralkylhaltige metallkomplexe und ihre verwendung in der tumortherapie und interventionellen radiologie
ZA975437B (en) New pyridyl alkene and pyridyl alkine acid amides.
ATE316377T1 (de) Tricyclopolyazamacrocyclophosphonsäuren, ihre komplexe und derivate, für eine verwendung als kontrastmittel
NO301829B1 (no) 2-pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og farmasöytiske preparater basert på disse
HUP0303665A2 (hu) Káliumcsatorna-blokkoló hatású arilezett furán- és tiofén-karbonsavamidok
ES2020011A6 (es) Metodo de sintesis de composiciones que comprenden al menos un butano fenolico.
BR0001254A (pt) Composição que compreende pelo menos um composto bicìclico aromático, utilização da composição e processo de solubilização de um composto bicìclico aromático
ATE223912T1 (de) Pyridylalkan-säureamide als cytostatika und immunosupressive arzneimittel
HRP20010584B1 (en) N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
DK0703897T3 (da) Lipoxinforbindelser med forlænget halveringstid
EA200001061A1 (ru) Фармацевтическая композиция
DK296389A (da) Farmaceutiske forbindelser
CY1105185T1 (el) Σταθepα σκευασματα ινσουλινης
KR950031085A (ko) 표피증식 질환 치료용 의약 조성물
ATE172721T1 (de) Aminosäurederivate und ihre verwendung als enkephalinase-inhibitoren
DE69822153D1 (de) Verwendung von stickstoffhaltigen aromatischen heterozyklusderivaten zur topischen behandlung von epithelerkrankungen
DE59705183D1 (de) Therapeutische mittel, enthaltend ebselen gegen asthma
DK0628039T3 (da) 2,3,4,5-tetrahydro-1H-benzazepiner og farmaceutisk acceptable syreadditionssalte deraf.
DE3673227D1 (de) 99mtc(iii)-agenzien zur myokardialen darstellung, in vivo nichtreduzierbar.
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
ES2065242A1 (es) Derivados del acido fenilacetico, procedimiento para su obtencion y utilizacion correspondiente.
EP0284069A3 (en) Benzopyranopyridineacetic acid ester compounds and their pharmaceutical uses
ATE40996T1 (de) Azolyl-aroxymethyl-dimethylpentinole.
DE60014358D1 (de) Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung
Antonyuzhenko et al. Occupational vegeto-sensor polyneuropathy of chemical ethiology (the peculiarities of formation, clinical picture and diagnosis)

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee